» Articles » PMID: 8844489

Severe Acute Hepatitis A Associated with Acute Pure Red Cell Aplasia

Overview
Journal J Gastroenterol
Specialty Gastroenterology
Date 1996 Aug 1
PMID 8844489
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A rare case of severe acute hepatitis A complicated by pure red cell aplasia (PRCA) is reported. A 60-year-old man with jaundice and hepatomegaly was diagnosed as having acute hepatitis A by positive IgM anti-hepatitis A antibody (anti-HAV). Severe anemia rapidly developed 3 weeks after admission, and the patient was diagnosed with PRCA by both bone marrow smears and erythrocyte survival study. The anemia was transient and bone marrow recovered within 1 week. However, concomitant with bone marrow recovery, the hepatitis worsened. He became drowsy and disoriented and severe jaundice, ascites, prolonged prothrombin time, increased transaminase levels, and abnormal electroencephalogram (EEG) were exhibited. Plasma exchange transfusion and glucagon-insulin (GI) therapy improved the consciousness level, but bilirubin, transaminase levels, and IgM anti-HAV titer remained high. Intravenous administration of lipophilized prostaglandin E1 (lipo-PGE1) was added to the GI therapy. Bilirubin and transaminase levels were normalized in the 8th week after the initiation of this combination therapy (17 weeks after admission). The combined use of lipo-PGE1 with plasma exchange and GI therapy appeared to be useful for the prolonged severe hepatitis in this patient.

Citing Articles

Treatment Options for Hepatitis A and E: A Non-Systematic Review.

Gabrielli F, Alberti F, Russo C, Cursaro C, Seferi H, Margotti M Viruses. 2023; 15(5).

PMID: 37243166 PMC: 10221699. DOI: 10.3390/v15051080.


Pure red cell aplasia in a three-months-old infant possibly secondary to cytomegalo virus infection.

Nandan D, Jahan A, Dewan V, Singh S, Buxi G Indian J Hematol Blood Transfus. 2014; 30(Suppl 1):30-2.

PMID: 25332527 PMC: 4192248. DOI: 10.1007/s12288-012-0226-z.


Pure red cell aplasia caused by acute hepatitis a.

Lee T, Oh S, Hong S, Lee K, Park H, Woo H Chonnam Med J. 2011; 47(1):51-3.

PMID: 22111059 PMC: 3214852. DOI: 10.4068/cmj.2011.47.1.51.


Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C.

Chang C, Yan S, Lin H, Yu F, Tsai C World J Gastroenterol. 2011; 17(16):2155-8.

PMID: 21547138 PMC: 3084404. DOI: 10.3748/wjg.v17.i16.2155.


Protective effects of prostaglandin E1 on hepatocytes.

Liu X, Fan D World J Gastroenterol. 2002; 6(3):326-329.

PMID: 11819590 PMC: 4688744. DOI: 10.3748/wjg.v6.i3.326.

References
1.
Canalese J, Wyke R, Vergani D, Eddleston A, Williams R . Circulating immune complexes in patients with fulminant hepatic failure. Gut. 1981; 22(10):845-8. PMC: 1419432. DOI: 10.1136/gut.22.10.845. View

2.
Mizoguchi Y, Tsutsui H, Miyajima K, Sakagami Y, Seki S, Kobayashi K . The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology. 1987; 7(6):1184-8. DOI: 10.1002/hep.1840070603. View

3.
Tomiyama J, Kudou H, Adachi Y, Kinugasa K, Hanada T . [A case of pure red cell aplasia following hepatitis A]. Rinsho Ketsueki. 1987; 28(12):2187-92. View

4.
Robert A . Cytoprotection by prostaglandins. Gastroenterology. 1979; 77(4 Pt 1):761-7. View

5.
Abecassis M, Falk J, Makowka L, Dindzans V, Falk R, Levy G . 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987; 80(3):881-9. PMC: 442316. DOI: 10.1172/JCI113147. View